Table 5 Comparison of test results depending on the severity of AAV
Disease form | ANCA(IU/ml) | WBC(x10,0\cr^9/l) | Hb(g/dl) | PLT(x10,0\cr^9/l) | ESR(mm/1Â h) | CRP(mg/dl) |
|---|---|---|---|---|---|---|
localized and early systemic n = 6 | 89,0(22,2;161,5) | 11,49(8,75;14,6) | 11,7(10,2;12,0) | 240,5(153,7;328) | 23,0(14,0;37,2) | 0,25(0,1;1,75) |
generalized n = 10 | 54,0(18,9;97,7) | 8,9(7,98;11,3) | 10,9(8,5;12,5) | 262,5(232;451,7) | 43,5(24,7;85,5) | 1,4(0,35;3,9) |
severe n = 12 | 53,0(5,92;171,5) | 10,3(8,92;15,6) | 8,65(7,7;10,1) | 285,0(186;315,7) | 85,0(57;111) | 6,9(2,17;18) |
P * | 0,661 | 0,285 | 0,009 | 0,577 | 0,007 | 0,006 |
P** | 0,685 | 0,639 | 0,003 | 0,685 | 0,002 | 0,001 |
Disease form | PCT(ng/ml) | Albumin(g/dl) | Fibrinogen(mg/dl) | D-dimer(µg/ml) | C3(mg/dl) | C4 (mg/dl) |
localized and early systemic n = 6 | 0,04(0,027;0,11) | 4,3(3,9;4,5) | 324(255;436) | 1,08(0,49;4,04) | 113,5(100;127) | 28(23,5;29) |
generalized n = 10 | 0,07(0,05;0,27) | 3,65(3,15;4,37) | 426(341;460) | 0,77(0,48;2,39) | 113,5(104;135) | 22(17,7;24) |
severe n = 12 | 0,91(0,4;2,94) | 3,2(2,95;3,7) | 590(485;716) | 8,5(2,83;17,3) | 124,0(98;134) | 22(18;30) |
P * | 0,000 | 0,043 | 0,009 | 0,001 | 0,966 | 0,292 |
P** | 0,000 | 0,013 | 0,001 | 0,001 | 0,875 | 0,333 |